The US Food and Drug Administration (FDA) has recently issued an Emergency Use
Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines …

Hypersensitivity reactions (HSRs) to chemotherapy agents can present a serious challenge
to treating patients with preferred or first-line therapies. Allergic reactions through an …

Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

Background The Centers for Disease Control and Prevention state that a severe or
immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a …

Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave
patients and doctors in a difficult position where an essential treatment or intervention has to …

Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre-including this research content-immediately …

Drug-induced anaphylaxis is a hyperacute reaction affecting multiple organs that can be of
fatal consequence. Its incidence is increasing, consistent with a global increased …

Background Penicillins (PCNs) are a first-line treatment option for bacterial pneumonia. PCN
allergy label can delay antimicrobial treatment and result in the use of alternative antibiotic …

Hypersensitivity reactions (HSRs) to chemotherapy may prevent patients from receiving the
most effective therapy. This review was undertaken to identify evidence-based preventive …

Objective The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the most rapid response and …